查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1771482

DNA製造市場規模、佔有率、趨勢分析報告：按類型、等級、應用、最終用途、地區、細分市場預測，2025-2030年

DNA Manufacturing Market Size, Share & Trends Analysis Report By Type, By Grade, By Application, By End-use, By Region, And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 150 Pages | 商品交期: 2-10個工作天內

價格

DNA製造市場的成長與趨勢：

根據Grand View Research, Inc.的最新報告，全球DNA製造市場規模預計到2030年將達到149.6億美元，2025年至2030年期間的複合年成長率為18.10%。

隨著合成生物學應用、個人化治療和先進疫苗開發需求的不斷成長，DNA製造市場正在快速發展。生物技術公司、學術機構以及合約開發與生產組織 (CDMO) 之間日益加強的合作正在加速創新並擴大市場准入。基因合成、酶促 DNA 生產和自動化技術的進步正在提高 DNA 製造流程的擴充性、速度和精確度。

由於其在基因治療、mRNA 疫苗、診斷檢測開發、細胞工程等各種應用中發揮關鍵作用，該市場正在獲得發展動力。隨著對高品質質體DNA 和 GMP 級材料的需求增加，新興企業和傳統供應商正在擴大其產能以滿足全球需求。

酶合成、無細胞系統和連續生產領域的創新正在重塑傳統工作流程，並縮短週轉時間。這些進步推動了基於DNA的工具在腫瘤學、感染疾病和再生醫學領域的廣泛應用。

隨著該領域的成熟，DNA製造市場將成為推動下一代生物治療、診斷和精準醫療解決方案的核心。

DNA製造市場報告重點

  • 按類型分類，合成DNA在2024年佔據了DNA製造市場的主導地位。這種主導地位歸功於其靈活性、擴充性以及在合成生物學、基因組編輯、診斷和下一代療法中日益成長的作用。酵素合成和自動化技術的進步顯著縮短了製造時間和成本，使得快速、高保真地產生客製化DNA序列成為可能。隨著製藥、農業和工業生物技術領域對精準工程DNA的需求不斷成長，合成DNA在創新和應用方面的表現持續超越傳統方法。
  • 按等級分類，2024 年研發級 DNA 佔據了 DNA 製造市場的主導地位。這種主導地位主要歸功於研發級 DNA 在學術機構、生技新興企業和早期藥物開發的廣泛應用。基因編輯、合成生物學和疫苗研究領域的創新加速，持續推動對用於實驗和臨床前試驗的經濟高效、高品質 DNA 的需求。研發級 DNA 的靈活性和快速的周轉時間使其成為迭代測試、概念驗證試驗和技術開發的重要資源。
  • 從應用角度來看，細胞和基因治療將在2024年佔據DNA製造市場的主導地位，佔據43.90%的市場佔有率。這一領先地位得益於針對癌症、罕見遺傳疾病和再生醫學的基因治療平台的快速發展。細胞和基因治療產品線對用作載體、模板和原料的高純度質體和合成DNA的需求旺盛，大大推動了生產需求。
  • 從最終用途來看，製藥和生物技術公司在2024年佔據了DNA製造市場的主導地位，佔據了48.68%的市場佔有率。基因治療、疫苗生產和生技藥品開發領域對DNA相關投入的需求激增，推動了這一主導地位。隨著這些公司推進臨床研發管線並將新型療法推向市場，它們對高品質、可擴展的DNA製造的依賴也日益成長。 DNA技術在精準醫療、腫瘤學和罕見疾病治療領域的日益普及，也進一步鞏固了它們在該領域的領導地位。
  • 2025年5月，專注於核酸療法的受託製造廠商(CDMO) VGXI, Inc. 宣布其位於德克薩斯州康羅市的工廠已成功通過美國食品藥物管理局(FDA) 的檢查。這一里程碑使 VGXI 的客戶能夠提交涉及質體DNA（基因療法和 mRNA 疫苗的關鍵成分）臨床試驗的生技藥品核准申請 (BLA)。 VGXI 的成就彰顯了其在質體DNA 生產領域的領先地位，提供可擴展的高純度生產能力。該公司是值得信賴的合作夥伴，致力於在全球範圍內推動改變生命的醫學研究和創新。

目錄

第1章調查方法與範圍

第2章執行摘要

第3章市場變數、趨勢和範圍

  • 市場體系展望
    • 母市場展望
    • 相關/附隨市場展望
  • 市場動態
    • 市場促進因素分析
    • 市場限制因素分析
  • DNA製造市場的分析工具
    • 產業分析-波特五力分析
    • PESTEL分析
    • COVID-19影響分析

第4章 DNA 製造市場：按類型分類的業務分析

  • 類型細分細分儀表板
  • 全球 DNA 製造市場：按類型進行差異分析
  • 2018 年至 2030 年全球 DNA 製造市場規模及趨勢分析（按類型）
  • 質體DNA
  • 合成DNA

第5章 DNA 製造市場：依等級分類的業務分析

  • 等級細分儀表板
  • 全球 DNA 製造市場：依等級的差異分析
  • 全球 DNA 製造市場規模與趨勢分析（按等級，2018-2030 年）
  • GMP級
  • 研發級

第6章 DNA 製造市場：按應用進行的業務分析

  • 應用程式細分儀表板
  • 全球 DNA 製造市場：按應用進行差異分析
  • 全球 DNA 製造市場規模與趨勢分析（按應用，2018-2030 年）
  • 細胞和基因治療
  • 疫苗
  • 寡核苷酸藥物
  • 其他

第 7 章 DNA 製造市場：按最終用途的業務分析

  • 最終用途細分儀表板
  • 全球 DNA 製造市場：按最終用途進行差異分析
  • 2018 年至 2030 年全球 DNA 製造市場規模及趨勢分析（依最終用途）
  • 製藥和生物技術公司
  • 學術研究所
  • 合約研究組織

第 8 章 DNA 製造市場：區域估計與趨勢分析

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 挪威
    • 瑞典
    • 丹麥
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 泰國
    • 韓國
    • 澳洲
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中東和非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第9章 競爭態勢

  • 公司分類
  • 戰略地圖
  • 2024年企業市場分析
  • 公司簡介/上市公司
    • Charles River Laboratories
    • VGXI, Inc.
    • Danaher（Aldevron）
    • Thermo Fisher Scientific
    • Lonza
    • GenScript
    • Catalent
    • Wuxi AppTec
    • Kaneka Corp.
    • Eurofins Genomics
Product Code: GVR-4-68040-608-4

DNA Manufacturing Market Growth & Trends:

The global DNA manufacturing market size is projected to reach USD 14.96 billion by 2030, growing at a CAGR of 18.10% from 2025 to 2030, according to a new report by Grand View Research, Inc. The DNA manufacturing market is rapidly evolving, driven by rising demand for synthetic biology applications, personalized therapeutics, and advanced vaccine development. Increasing collaboration between biotech firms, academic institutions, and contract development and manufacturing organizations (CDMOs) is accelerating innovation and expanding market access. Technological advancements in gene synthesis, enzymatic DNA production, and automation enhance DNA manufacturing processes' scalability, speed, and precision.

This market is gaining momentum due to its critical role in various applications, including gene therapy, mRNA vaccines, diagnostic assay development, and cell engineering. As the need for high-quality plasmid DNA and GMP-grade materials grows, startups and legacy providers are expanding their capabilities to meet global demand.

Innovations in enzymatic synthesis, cell-free systems, and continuous manufacturing are reshaping traditional workflows and enabling faster turnaround times. These advancements support the broader adoption of DNA-based tools in oncology, infectious diseases, and regenerative medicine.

As the field matures, the DNA manufacturing market is positioned to be central in advancing the next generation of biotherapeutics, diagnostics, and precision health solutions.

DNA Manufacturing Market Report Highlights:

  • Based on type, synthetic DNA dominated the DNA manufacturing market in 2024. This dominance is attributed to its flexibility, scalability, and expanding role in synthetic biology, genome editing, diagnostics, and next-generation therapeutics. Advances in enzymatic synthesis and automation have significantly reduced production time and costs, enabling the rapid, high-fidelity generation of custom DNA sequences. As demand grows for precision-engineered DNA across pharmaceutical, agricultural, and industrial biotech sectors, synthetic DNA continues to outpace traditional methods in innovation and adoption.
  • Based on grade, R&D-grade DNA dominated the DNA manufacturing market in 2024. This dominance is primarily due to the widespread use of research-grade DNA in academic institutions, biotech startups, and early-stage drug development. Innovation in gene editing, synthetic biology, and vaccine research accelerates, and demand for cost-effective, high-quality DNA for experimental and preclinical studies continues to rise. The flexibility and faster turnaround of R&D-grade DNA make it an essential resource in iterative testing, proof-of-concept studies, and technology development.
  • Based on application, cell and gene therapy dominated the DNA manufacturing market in 2024, accounting for 43.90% market share. This leadership is driven by the rapid advancement of gene-based therapeutic platforms targeting cancer, rare genetic disorders, and regenerative medicine. High demand for high-purity plasmid and synthetic DNA for use as vectors, templates, or raw material in cell and gene therapy pipelines has significantly increased production requirements.
  • Based on end use, pharmaceutical and biotechnology companies dominated the DNA manufacturing market in 2024, accounting for 48.68% market share. The surge in demand for DNA-based inputs across gene therapy, vaccine production, and biologics development drives this dominance. As these companies advance clinical pipelines and bring novel therapeutics to market, their reliance on high-quality, scalable DNA manufacturing continues to grow. The increasing adoption of DNA technologies in precision medicine, oncology, and rare disease treatment further reinforces this segment's leadership.
  • In May 2025, VGXI, Inc., a contract development and manufacturing organization (CDMO) specializing in nucleic acid-based therapeutics, announced the successful completion of a U.S. Food and Drug Administration (FDA) inspection at its Conroe, Texas facility. This milestone enables VGXI's client to submit a Biologics License Application (BLA) for clinical trials involving plasmid DNA, a critical component in gene therapies and mRNA vaccines. VGXI's achievement underscores its leadership in plasmid DNA manufacturing, offering scalable and high-purity production capabilities. The company has been a trusted partner in advancing life-changing medical research and innovation worldwide

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Market Definitions
    • 1.2.1. Type Segment
    • 1.2.2. Grade Segment
    • 1.2.3. Application Segment
    • 1.2.4. End Use Segment
  • 1.3. Information analysis
  • 1.4. Market formulation & data visualization
  • 1.5. Data validation & publishing
  • 1.6. Information Procurement
    • 1.6.1. Primary Research
  • 1.7. Information or Data Analysis
  • 1.8. Market Formulation & Validation
  • 1.9. Market Model
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
    • 3.2.2. Market restraint analysis
  • 3.3. DNA Manufacturing Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
    • 3.3.2. PESTEL Analysis
    • 3.3.3. COVID-19 Impact Analysis

Chapter 4. DNA Manufacturing Market: Type Business Analysis

  • 4.1. Type Segment Dashboard
  • 4.2. Global DNA Manufacturing Market Type Movement Analysis
  • 4.3. Global DNA Manufacturing Market Size & Trend Analysis, by Type, 2018 to 2030 (USD Million)
  • 4.4. Plasmid DNA
    • 4.4.1. Global Plasmid DNA based Market, 2018 - 2030 (USD Million)
  • 4.5. Synthetic DNA
    • 4.5.1. Global Synthetic DNA Market, 2018 - 2030 (USD Million)
      • 4.5.1.1. Gene Synthesis
        • 4.5.1.1.1. Global Gene Synthesis Market, 2018 - 2030 (USD Million)
      • 4.5.1.2. Oligonucleotide Synthesis
        • 4.5.1.2.1. Global Oligonucleotide Synthesis Market, 2018 - 2030 (USD Million)

Chapter 5. DNA Manufacturing Market: Grade Business Analysis

  • 5.1. Grade Segment Dashboard
  • 5.2. Global DNA Manufacturing Market Grade Movement Analysis
  • 5.3. Global DNA Manufacturing Market Size & Trend Analysis, by Grade, 2018 to 2030 (USD Million)
  • 5.4. GMP Grade
    • 5.4.1. Global GMP Grade Market, 2018 - 2030 (USD Million)
  • 5.5. R&D Grade
    • 5.5.1. Global R&D Grade Market, 2018 - 2030 (USD Million)

Chapter 6. DNA Manufacturing Market: Application Business Analysis

  • 6.1. Application Segment Dashboard
  • 6.2. Global DNA Manufacturing Market Application Movement Analysis
  • 6.3. Global DNA Manufacturing Market Size & Trend Analysis, by Application, 2018 to 2030 (USD Million)
  • 6.4. Cell & Gene Therapy
    • 6.4.1. Global Cell & Gene Therapy Market, 2018 - 2030 (USD Million)
  • 6.5. Vaccines
    • 6.5.1. Global Vaccines Market, 2018 - 2030 (USD Million)
  • 6.6. Oligonucleotide-based Drugs
    • 6.6.1. Global Oligonucleotide-based Drugs Market, 2018 - 2030 (USD Million)
  • 6.7. Others
    • 6.7.1. Global Others Market, 2018 - 2030 (USD Million)

Chapter 7. DNA Manufacturing Market: End Use Business Analysis

  • 7.1. End Use Segment Dashboard
  • 7.2. Global DNA Manufacturing Market End Use Movement Analysis
  • 7.3. Global DNA Manufacturing Market Size & Trend Analysis, by End Use, 2018 to 2030 (USD Million)
  • 7.4. Pharmaceutical and Biotechnology Companies
    • 7.4.1. Global Pharmaceutical and Biotechnology Companies Devices Market, 2018 - 2030 (USD Million)
  • 7.5. Academic & Research Institutes
    • 7.5.1. Global Academic & Research Institutes Market, 2018 - 2030 (USD Million)
  • 7.6. Contract Research Organizations
    • 7.6.1. Global Contract Research Organizations Market, 2018 - 2030 (USD Million)

Chapter 8. Regional DNA Manufacturing Market: Region Estimates & Trend Analysis

  • 8.1. North America
    • 8.1.1. North America market estimates and forecasts 2018 - 2030 (USD Million)
    • 8.1.2. U.S.
      • 8.1.2.1. Key country dynamics
      • 8.1.2.2. Competitive scenario
      • 8.1.2.3. Regulatory Framework
      • 8.1.2.4. Target Disease Prevalence
      • 8.1.2.5. U.S. market estimates and forecasts 2018 - 2030 (USD Million)
    • 8.1.3. Canada
      • 8.1.3.1. Key country dynamics
      • 8.1.3.2. Competitive scenario
      • 8.1.3.3. Regulatory Framework
      • 8.1.3.4. Target Disease Prevalence
      • 8.1.3.5. Canada market estimates and forecasts 2018 - 2030 (USD Million)
    • 8.1.4. Mexico
      • 8.1.4.1. Key country dynamics
      • 8.1.4.2. Competitive scenario
      • 8.1.4.3. Regulatory Framework
      • 8.1.4.4. Target Disease Prevalence
      • 8.1.4.5. Mexico market estimates and forecasts 2018 - 2030 (USD Million)
  • 8.2. Europe
    • 8.2.1. Europe market estimates and forecasts 2018 - 2030 (USD Million)
    • 8.2.2. UK
      • 8.2.2.1. Key country dynamics
      • 8.2.2.2. Competitive scenario
      • 8.2.2.3. Regulatory Framework
      • 8.2.2.4. Target Disease Prevalence
      • 8.2.2.5. UK market estimates and forecasts 2018 - 2030 (USD Million)
    • 8.2.3. Germany
      • 8.2.3.1. Key country dynamics
      • 8.2.3.2. Competitive scenario
      • 8.2.3.3. Regulatory Framework
      • 8.2.3.4. Target Disease Prevalence
      • 8.2.3.5. Germany market estimates and forecasts 2018 - 2030 (USD Million)
    • 8.2.4. France
      • 8.2.4.1. Key country dynamics
      • 8.2.4.2. Competitive scenario
      • 8.2.4.3. Regulatory Framework
      • 8.2.4.4. Target Disease Prevalence
      • 8.2.4.5. France market estimates and forecasts 2018 - 2030 (USD Million)
    • 8.2.5. Italy
      • 8.2.5.1. Key country dynamics
      • 8.2.5.2. Competitive scenario
      • 8.2.5.3. Regulatory Framework
      • 8.2.5.4. Target Disease Prevalence
      • 8.2.5.5. Italy market estimates and forecasts 2018 - 2030 (USD Million)
    • 8.2.6. Spain
      • 8.2.6.1. Key country dynamics
      • 8.2.6.2. Competitive scenario
      • 8.2.6.3. Regulatory Framework
      • 8.2.6.4. Target Disease Prevalence
      • 8.2.6.5. Spain market estimates and forecasts 2018 - 2030 (USD Million)
    • 8.2.7. Norway
      • 8.2.7.1. Key country dynamics
      • 8.2.7.2. Competitive scenario
      • 8.2.7.3. Regulatory Framework
      • 8.2.7.4. Target Disease Prevalence
      • 8.2.7.5. Norway market estimates and forecasts 2018 - 2030 (USD Million)
    • 8.2.8. Sweden
      • 8.2.8.1. Key country dynamics
      • 8.2.8.2. Competitive scenario
      • 8.2.8.3. Regulatory Framework
      • 8.2.8.4. Target Disease Prevalence
      • 8.2.8.5. Sweden market estimates and forecasts 2018 - 2030 (USD Million)
    • 8.2.9. Denmark
      • 8.2.9.1. Key country dynamics
      • 8.2.9.2. Competitive scenario
      • 8.2.9.3. Regulatory Framework
      • 8.2.9.4. Target Disease Prevalence
      • 8.2.9.5. Denmark market estimates and forecasts 2018 - 2030 (USD Million)
  • 8.3. Asia Pacific
    • 8.3.1. Asia Pacific market estimates and forecasts 2018 - 2030 (USD Million)
    • 8.3.2. Japan
      • 8.3.2.1. Key country dynamics
      • 8.3.2.2. Competitive scenario
      • 8.3.2.3. Regulatory Framework
      • 8.3.2.4. Target Disease Prevalence
      • 8.3.2.5. Japan market estimates and forecasts 2018 - 2030 (USD Million)
    • 8.3.3. China
      • 8.3.3.1. Key country dynamics
      • 8.3.3.2. Competitive scenario
      • 8.3.3.3. Regulatory Framework
      • 8.3.3.4. Target Disease Prevalence
      • 8.3.3.5. China market estimates and forecasts 2018 - 2030 (USD Million)
    • 8.3.4. India
      • 8.3.4.1. Key country dynamics
      • 8.3.4.2. Competitive scenario
      • 8.3.4.3. Regulatory Framework
      • 8.3.4.4. Target Disease Prevalence
      • 8.3.4.5. India market estimates and forecasts 2018 - 2030 (USD Million)
    • 8.3.5. Thailand
      • 8.3.5.1. Key country dynamics
      • 8.3.5.2. Competitive scenario
      • 8.3.5.3. Regulatory Framework
      • 8.3.5.4. Target Disease Prevalence
      • 8.3.5.5. Thailand market estimates and forecasts 2018 - 2030 (USD Million)
    • 8.3.6. South Korea
      • 8.3.6.1. Key country dynamics
      • 8.3.6.2. Competitive scenario
      • 8.3.6.3. Regulatory Framework
      • 8.3.6.4. Target Disease Prevalence
      • 8.3.6.5. South Korea market estimates and forecasts 2018 - 2030 (USD Million)
    • 8.3.7. Australia
      • 8.3.7.1. Key country dynamics
      • 8.3.7.2. Competitive scenario
      • 8.3.7.3. Regulatory Framework
      • 8.3.7.4. Target Disease Prevalence
      • 8.3.7.5. Australia market estimates and forecasts 2018 - 2030 (USD Million)
  • 8.4. Latin America
    • 8.4.1. Latin America market estimates and forecasts 2018 - 2030 (USD Million)
    • 8.4.2. Brazil
      • 8.4.2.1. Key country dynamics
      • 8.4.2.2. Competitive scenario
      • 8.4.2.3. Regulatory Framework
      • 8.4.2.4. Target Disease Prevalence
      • 8.4.2.5. Brazil market estimates and forecasts 2018 - 2030 (USD Million)
    • 8.4.3. Argentina
      • 8.4.3.1. Key country dynamics
      • 8.4.3.2. Competitive scenario
      • 8.4.3.3. Regulatory Framework
      • 8.4.3.4. Target Disease Prevalence
      • 8.4.3.5. Argentina market estimates and forecasts 2018 - 2030 (USD Million)
  • 8.5. Middle East & Africa
    • 8.5.1. Middle East & Africa market estimates and forecasts 2018 - 2030 (USD Million)
    • 8.5.2. South Africa
      • 8.5.2.1. Key country dynamics
      • 8.5.2.2. Competitive scenario
      • 8.5.2.3. Regulatory Framework
      • 8.5.2.4. Target Disease Prevalence
      • 8.5.2.5. South Africa market estimates and forecasts 2018 - 2030 (USD Million)
    • 8.5.3. Saudi Arabia
      • 8.5.3.1. Key country dynamics
      • 8.5.3.2. Competitive scenario
      • 8.5.3.3. Regulatory Framework
      • 8.5.3.4. Target Disease Prevalence
      • 8.5.3.5. Saudi Arabia market estimates and forecasts 2018 - 2030 (USD Million)
    • 8.5.4. UAE
      • 8.5.4.1. Key country dynamics
      • 8.5.4.2. Competitive scenario
      • 8.5.4.3. Regulatory Framework
      • 8.5.4.4. Target Disease Prevalence
      • 8.5.4.5. UAE market estimates and forecasts 2018 - 2030 (USD Million)
    • 8.5.5. Kuwait
      • 8.5.5.1. Key country dynamics
      • 8.5.5.2. Competitive scenario
      • 8.5.5.3. Regulatory Framework
      • 8.5.5.4. Target Disease Prevalence
      • 8.5.5.5. Kuwait market estimates and forecasts 2018 - 2030 (USD Million)

Chapter 9. Competitive Landscape

  • 9.1. Company Categorization
  • 9.2. Strategy Mapping
  • 9.3. Company Market Position Analysis, 2024
  • 9.4. Company Profiles/Listing
    • 9.4.1. Charles River Laboratories
      • 9.4.1.1. Overview
      • 9.4.1.2. Financial Performance
      • 9.4.1.3. Service Benchmarking
      • 9.4.1.4. Strategic Initiatives
    • 9.4.2. VGXI, Inc.
      • 9.4.2.1. Overview
      • 9.4.2.2. Financial Performance
      • 9.4.2.3. Service Benchmarking
      • 9.4.2.4. Strategic Initiatives
    • 9.4.3. Danaher (Aldevron)
      • 9.4.3.1. Overview
      • 9.4.3.2. Financial Performance
      • 9.4.3.3. Service Benchmarking
      • 9.4.3.4. Strategic Initiatives
    • 9.4.4. Thermo Fisher Scientific
      • 9.4.4.1. Overview
      • 9.4.4.2. Financial Performance
      • 9.4.4.3. Service Benchmarking
      • 9.4.4.4. Strategic Initiatives
    • 9.4.5. Lonza
      • 9.4.5.1. Overview
      • 9.4.5.2. Financial Performance
      • 9.4.5.3. Service Benchmarking
      • 9.4.5.4. Strategic Initiatives
    • 9.4.6. GenScript
      • 9.4.6.1. Overview
      • 9.4.6.2. Financial Performance
      • 9.4.6.3. Service Benchmarking
      • 9.4.6.4. Strategic Initiatives
    • 9.4.7. Catalent
      • 9.4.7.1. Overview
      • 9.4.7.2. Financial Performance
      • 9.4.7.3. Service Benchmarking
      • 9.4.7.4. Strategic Initiatives
    • 9.4.8. Wuxi AppTec
      • 9.4.8.1. Overview
      • 9.4.8.2. Financial Performance
      • 9.4.8.3. Service Benchmarking
      • 9.4.8.4. Strategic Initiatives
    • 9.4.9. Kaneka Corp.
      • 9.4.9.1. Overview
      • 9.4.9.2. Financial Performance
      • 9.4.9.3. Service Benchmarking
      • 9.4.9.4. Strategic Initiatives
    • 9.4.10. Eurofins Genomics
      • 9.4.10.1. Overview
      • 9.4.10.2. Financial Performance
      • 9.4.10.3. Service Benchmarking
      • 9.4.10.4. Strategic Initiatives

List of Tables

  • Table 1 North America DNA manufacturing market estimates & forecasts
  • Table 2 North America DNA manufacturing market estimates & forecasts, by type, 2018 - 2030 (USD Million)
  • Table 3 North America DNA manufacturing market estimates & forecasts, by grade, 2018 - 2030 (USD Million)
  • Table 4 North America DNA manufacturing market estimates & forecasts, by application, 2018 - 2030 (USD Million)
  • Table 5 North America DNA manufacturing market estimates & forecasts, by end use, 2018 - 2030 (USD Million)
  • Table 6 U.S DNA manufacturing market estimates & forecasts, by type, 2018 - 2030 (USD Million)
  • Table 7 U.S DNA manufacturing market estimates & forecasts, by grade, 2018 - 2030 (USD Million)
  • Table 8 U.S DNA manufacturing market estimates & forecasts, by application, 2018 - 2030 (USD Million)
  • Table 9 U.S DNA manufacturing market estimates & forecasts, by end use, 2018 - 2030 (USD Million)
  • Table 10 Canada DNA manufacturing market estimates & forecasts, by type, 2018 - 2030 (USD Million)
  • Table 11 Canada DNA manufacturing market estimates & forecasts, by grade, 2018 - 2030 (USD Million)
  • Table 12 Canada DNA manufacturing market estimates & forecasts, by application, 2018 - 2030 (USD Million)
  • Table 13 Canada DNA manufacturing market estimates & forecasts, by end use, 2018 - 2030 (USD Million)
  • Table 14 Mexico DNA manufacturing market estimates & forecasts, by type, 2018 - 2030 (USD Million)
  • Table 15 Mexico DNA manufacturing market estimates & forecasts, by grade, 2018 - 2030 (USD Million)
  • Table 16 Mexico DNA manufacturing market estimates & forecasts, by application, 2018 - 2030 (USD Million)
  • Table 17 Mexico DNA manufacturing market estimates & forecasts, by end use, 2018 - 2030 (USD Million)
  • Table 18 Europe DNA manufacturing market estimates & forecasts
  • Table 19 Europe DNA manufacturing market estimates & forecasts, by type, 2018 - 2030 (USD Million)
  • Table 20 Europe DNA manufacturing market estimates & forecasts, by grade, 2018 - 2030 (USD Million)
  • Table 21 Europe DNA manufacturing market estimates & forecasts, by application, 2018 - 2030 (USD Million)
  • Table 22 Europe DNA manufacturing market estimates & forecasts, by end use, 2018 - 2030 (USD Million)
  • Table 23 UK DNA manufacturing market estimates & forecasts, by type, 2018 - 2030 (USD Million)
  • Table 24 UK DNA manufacturing market estimates & forecasts, by grade, 2018 - 2030 (USD Million)
  • Table 25 UK DNA manufacturing market estimates & forecasts, by application, 2018 - 2030 (USD Million)
  • Table 26 UK DNA manufacturing market estimates & forecasts, by end use, 2018 - 2030 (USD Million)
  • Table 27 Germany DNA manufacturing market estimates & forecasts, by type, 2018 - 2030 (USD Million)
  • Table 28 Germany DNA manufacturing market estimates & forecasts, by grade, 2018 - 2030 (USD Million)
  • Table 29 Germany DNA manufacturing market estimates & forecasts, by application, 2018 - 2030 (USD Million)
  • Table 30 Germany DNA manufacturing market estimates & forecasts, by end use, 2018 - 2030 (USD Million)
  • Table 31 France DNA manufacturing market estimates & forecasts, by type, 2018 - 2030 (USD Million)
  • Table 32 France DNA manufacturing market estimates & forecasts, by grade, 2018 - 2030 (USD Million)
  • Table 33 France DNA manufacturing market estimates & forecasts, by application, 2018 - 2030 (USD Million)
  • Table 34 France DNA manufacturing market estimates & forecasts, by end use, 2018 - 2030 (USD Million)
  • Table 35 Spain DNA manufacturing market estimates & forecasts, by type, 2018 - 2030 (USD Million)
  • Table 36 Spain DNA manufacturing market estimates & forecasts, by grade, 2018 - 2030 (USD Million)
  • Table 37 Spain DNA manufacturing market estimates & forecasts, by application, 2018 - 2030 (USD Million)
  • Table 38 Spain DNA manufacturing market estimates & forecasts, by end use, 2018 - 2030 (USD Million)
  • Table 39 Italy DNA manufacturing market estimates & forecasts, by type, 2018 - 2030 (USD Million)
  • Table 40 Italy DNA manufacturing market estimates & forecasts, by grade, 2018 - 2030 (USD Million)
  • Table 41 Italy DNA manufacturing market estimates & forecasts, by application, 2018 - 2030 (USD Million)
  • Table 42 Italy DNA manufacturing market estimates & forecasts, by end use, 2018 - 2030 (USD Million)
  • Table 43 Denmark DNA manufacturing market estimates & forecasts, by type, 2018 - 2030 (USD Million)
  • Table 44 Denmark DNA manufacturing market estimates & forecasts, by grade, 2018 - 2030 (USD Million)
  • Table 45 Denmark DNA manufacturing market estimates & forecasts, by application, 2018 - 2030 (USD Million)
  • Table 46 Denmark DNA manufacturing market estimates & forecasts, by end use, 2018 - 2030 (USD Million)
  • Table 47 Sweden DNA manufacturing market estimates & forecasts, by type, 2018 - 2030 (USD Million)
  • Table 48 Sweden DNA manufacturing market estimates & forecasts, by grade, 2018 - 2030 (USD Million)
  • Table 49 Sweden DNA manufacturing market estimates & forecasts, by application, 2018 - 2030 (USD Million)
  • Table 50 Sweden DNA manufacturing market estimates & forecasts, by end use, 2018 - 2030 (USD Million)
  • Table 51 Norway DNA manufacturing market estimates & forecasts, by type, 2018 - 2030 (USD Million)
  • Table 52 Norway DNA manufacturing market estimates & forecasts, by grade, 2018 - 2030 (USD Million)
  • Table 53 Norway DNA manufacturing market estimates & forecasts, by application, 2018 - 2030 (USD Million)
  • Table 54 Norway DNA manufacturing market estimates & forecasts, by end use, 2018 - 2030 (USD Million)
  • Table 55 Asia Pacific DNA manufacturing market estimates & forecasts
  • Table 56 Asia Pacific DNA manufacturing market estimates & forecasts, by type, 2018 - 2030 (USD Million)
  • Table 57 Asia Pacific DNA manufacturing market estimates & forecasts, by grade, 2018 - 2030 (USD Million)
  • Table 58 Asia Pacific DNA manufacturing market estimates & forecasts, by application, 2018 - 2030 (USD Million)
  • Table 59 Asia Pacific DNA manufacturing market estimates & forecasts, by end use, 2018 - 2030 (USD Million)
  • Table 60 China DNA manufacturing market estimates & forecasts, by type, 2018 - 2030 (USD Million)
  • Table 61 China DNA manufacturing market estimates & forecasts, by grade, 2018 - 2030 (USD Million)
  • Table 62 China DNA manufacturing market estimates & forecasts, by application, 2018 - 2030 (USD Million)
  • Table 63 China DNA manufacturing market estimates & forecasts, by end use, 2018 - 2030 (USD Million)
  • Table 64 Japan DNA manufacturing market estimates & forecasts, by type, 2018 - 2030 (USD Million)
  • Table 65 Japan DNA manufacturing market estimates & forecasts, by grade, 2018 - 2030 (USD Million)
  • Table 66 Japan DNA manufacturing market estimates & forecasts, by application, 2018 - 2030 (USD Million)
  • Table 67 Japan DNA manufacturing market estimates & forecasts, by end use, 2018 - 2030 (USD Million)
  • Table 68 India DNA manufacturing market estimates & forecasts, by type, 2018 - 2030 (USD Million)
  • Table 69 India DNA manufacturing market estimates & forecasts, by grade, 2018 - 2030 (USD Million)
  • Table 70 India DNA manufacturing market estimates & forecasts, by application, 2018 - 2030 (USD Million)
  • Table 71 India DNA manufacturing market estimates & forecasts, by end use, 2018 - 2030 (USD Million)
  • Table 72 South Korea DNA manufacturing market estimates & forecasts, by type, 2018 - 2030 (USD Million)
  • Table 73 South Korea DNA manufacturing market estimates & forecasts, by grade, 2018 - 2030 (USD Million)
  • Table 74 South Korea DNA manufacturing market estimates & forecasts, by application, 2018 - 2030 (USD Million)
  • Table 75 South Korea DNA manufacturing market estimates & forecasts, by end use, 2018 - 2030 (USD Million)
  • Table 76 Australia DNA manufacturing market estimates & forecasts, by type, 2018 - 2030 (USD Million)
  • Table 77 Australia DNA manufacturing market estimates & forecasts, by grade, 2018 - 2030 (USD Million)
  • Table 78 Australia DNA manufacturing market estimates & forecasts, by application, 2018 - 2030 (USD Million)
  • Table 79 Australia DNA manufacturing market estimates & forecasts, by end use, 2018 - 2030 (USD Million)
  • Table 80 Thailand DNA manufacturing market estimates & forecasts, by type, 2018 - 2030 (USD Million)
  • Table 81 Thailand DNA manufacturing market estimates & forecasts, by grade, 2018 - 2030 (USD Million)
  • Table 82 Thailand DNA manufacturing market estimates & forecasts, by application, 2018 - 2030 (USD Million)
  • Table 83 Thailand DNA manufacturing market estimates & forecasts, by end use, 2018 - 2030 (USD Million)
  • Table 84 Latin America DNA manufacturing market estimates & forecasts
  • Table 85 Latin America DNA manufacturing market estimates & forecasts, by type, 2018 - 2030 (USD Million)
  • Table 86 Latin America DNA manufacturing market estimates & forecasts, by grade, 2018 - 2030 (USD Million)
  • Table 87 Latin America DNA manufacturing market estimates & forecasts, by application, 2018 - 2030 (USD Million)
  • Table 88 Latin America DNA manufacturing market estimates & forecasts, by end use, 2018 - 2030 (USD Million)
  • Table 89 Brazil DNA manufacturing market estimates & forecasts, by type, 2018 - 2030 (USD Million)
  • Table 90 Brazil DNA manufacturing market estimates & forecasts, by grade, 2018 - 2030 (USD Million)
  • Table 91 Brazil DNA manufacturing market estimates & forecasts, by application, 2018 - 2030 (USD Million)
  • Table 92 Brazil DNA manufacturing market estimates & forecasts, by end use, 2018 - 2030 (USD Million)
  • Table 93 Argentina DNA manufacturing market estimates & forecasts, by type, 2018 - 2030 (USD Million)
  • Table 94 Argentina DNA manufacturing market estimates & forecasts, by grade, 2018 - 2030 (USD Million)
  • Table 95 Argentina DNA manufacturing market estimates & forecasts, by application, 2018 - 2030 (USD Million)
  • Table 96 Argentina DNA manufacturing market estimates & forecasts, by end use, 2018 - 2030 (USD Million)
  • Table 97 MEA DNA manufacturing market estimates & forecasts
  • Table 98 MEA DNA manufacturing market estimates & forecasts, by type, 2018 - 2030 (USD Million)
  • Table 99 MEA DNA manufacturing market estimates & forecasts, by grade, 2018 - 2030 (USD Million)
  • Table 100 MEA DNA manufacturing market estimates & forecasts, by application, 2018 - 2030 (USD Million)
  • Table 101 MEA DNA manufacturing market estimates & forecasts, by end use, 2018 - 2030 (USD Million)
  • Table 102 South Africa DNA manufacturing market estimates & forecasts, by type, 2018 - 2030 (USD Million)
  • Table 103 South Africa DNA manufacturing market estimates & forecasts, by grade, 2018 - 2030 (USD Million)
  • Table 104 South Africa DNA manufacturing market estimates & forecasts, by application, 2018 - 2030 (USD Million)
  • Table 105 South Africa DNA manufacturing market estimates & forecasts, by end use, 2018 - 2030 (USD Million)
  • Table 106 Saudi Arabia DNA manufacturing market estimates & forecasts, by type, 2018 - 2030 (USD Million)
  • Table 107 Saudi Arabia DNA manufacturing market estimates & forecasts, by grade, 2018 - 2030 (USD Million)
  • Table 108 Saudi Arabia DNA manufacturing market estimates & forecasts, by application, 2018 - 2030 (USD Million)
  • Table 109 Saudi Arabia DNA manufacturing market estimates & forecasts, by end use, 2018 - 2030 (USD Million)
  • Table 110 UAE DNA manufacturing market estimates & forecasts, by type, 2018 - 2030 (USD Million)
  • Table 111 UAE DNA manufacturing market estimates & forecasts, by grade, 2018 - 2030 (USD Million)
  • Table 112 UAE DNA manufacturing market estimates & forecasts, by application, 2018 - 2030 (USD Million)
  • Table 113 UAE DNA manufacturing market estimates & forecasts, by end use, 2018 - 2030 (USD Million)
  • Table 114 Kuwait DNA manufacturing market estimates & forecasts, by type, 2018 - 2030 (USD Million)
  • Table 115 Kuwait DNA manufacturing market estimates & forecasts, by grade, 2018 - 2030 (USD Million)
  • Table 116 Kuwait DNA manufacturing market estimates & forecasts, by application, 2018 - 2030 (USD Million)
  • Table 117 Kuwait DNA manufacturing market estimates & forecasts, by end use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market snapshot
  • Fig. 2 Market research process
  • Fig. 3 Information procurement
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Market trends & outlook
  • Fig. 7 Market segmentation & scope
  • Fig. 8 Market driver relevance analysis (Current & future impact)
  • Fig. 9 Market restraint relevance analysis (Current & future impact)
  • Fig. 10 PESTLE Analysis
  • Fig. 11 Porter's Five Forces Analysis
  • Fig. 12 Strategy framework
  • Fig. 13 DNA manufacturing market: Type outlook key takeaways
  • Fig. 14 DNA manufacturing market: Type movement analysis
  • Fig. 15 Plasmid DNA market, 2018 - 2030 (USD Million)
  • Fig. 16 Synthetic DNA market, 2018 - 2030 (USD Million)
  • Fig. 17 Gene synthesis market, 2018 - 2030 (USD Million)
  • Fig. 18 Oligonucleotide synthesis market, 2018 - 2030 (USD Million)
  • Fig. 19 DNA Manufacturing market: Grade outlook key takeaways
  • Fig. 20 DNA Manufacturing market: Grade movement analysis
  • Fig. 21 GMP grade market, 2018 - 2030 (USD Million)
  • Fig. 22 R&D grade market, 2018 - 2030 (USD Million)
  • Fig. 23 DNA manufacturing market: Application outlook key takeaways
  • Fig. 24 DNA manufacturing market: Application movement analysis
  • Fig. 25 Cell & gene therapy market, 2018 - 2030 (USD Million)
  • Fig. 26 Vaccines market, 2018 - 2030 (USD Million)
  • Fig. 27 Oligonucleotide-based drugs market, 2018 - 2030 (USD Million)
  • Fig. 28 Others market, 2018 - 2030 (USD Million)
  • Fig. 29 DNA Manufacturing market: End Use outlook key takeaways
  • Fig. 30 DNA Manufacturing market: End Use movement analysis
  • Fig. 31 Pharmaceutical and biotechnology companies market, 2018 - 2030 (USD Million)
  • Fig. 32 Contract research organizations market, 2018 - 2030 (USD Million)
  • Fig. 33 Academic & research institutes market, 2018 - 2030 (USD Million)
  • Fig. 34 DNA manufacturing market, by region, 2018 - 2030 (USD Million)
  • Fig. 35 North America DNA manufacturing market, by country, 2018 - 2030 (USD Million)
  • Fig. 36 U.S. DNA manufacturing market, 2018 - 2030 (USD Million)
  • Fig. 37 Canada DNA manufacturing market, 2018 - 2030 (USD Million)
  • Fig. 38 Mexico DNA manufacturing market, 2018 - 2030 (USD Million)
  • Fig. 39 Europe DNA manufacturing market, by country, 2018 - 2030 (USD Million)
  • Fig. 40 UK DNA manufacturing market, 2018 - 2030 (USD Million)
  • Fig. 41 Germany DNA manufacturing market, 2018 - 2030 (USD Million)
  • Fig. 42 France DNA manufacturing market, 2018 - 2030 (USD Million)
  • Fig. 43 Italy DNA manufacturing market, 2018 - 2030 (USD Million)
  • Fig. 44 Spain DNA manufacturing market, 2018 - 2030 (USD Million)
  • Fig. 45 Denmark DNA manufacturing market, 2018 - 2030 (USD Million)
  • Fig. 46 Sweden DNA manufacturing market, 2018 - 2030 (USD Million)
  • Fig. 47 Norway DNA manufacturing market, 2018 - 2030 (USD Million)
  • Fig. 48 Asia Pacific DNA manufacturing market, by country, 2018 - 2030 (USD Million)
  • Fig. 49 Japan DNA manufacturing market, 2018 - 2030 (USD Million)
  • Fig. 50 China DNA manufacturing market, 2018 - 2030 (USD Million)
  • Fig. 51 India DNA manufacturing market, 2018 - 2030 (USD Million)
  • Fig. 52 Australia DNA manufacturing market, 2018 - 2030 (USD Million)
  • Fig. 53 South Korea DNA manufacturing market, 2018 - 2030 (USD Million)
  • Fig. 54 Thailand DNA manufacturing market, 2018 - 2030 (USD Million)
  • Fig. 55 Latin America DNA manufacturing market, by country, 2018 - 2030 (USD Million)
  • Fig. 56 Brazil DNA manufacturing market, 2018 - 2030 (USD Million)
  • Fig. 57 Argentina DNA manufacturing market, 2018 - 2030 (USD Million)
  • Fig. 58 Middle East & Africa DNA manufacturing market, by country, 2018 - 2030 (USD Million)
  • Fig. 59 South Africa DNA manufacturing market, 2018 - 2030 (USD Million)
  • Fig. 60 Saudi Arabia DNA manufacturing market, 2018 - 2030 (USD Million)
  • Fig. 61 UAE DNA manufacturing market, 2018 - 2030 (USD Million)
  • Fig. 62 Kuwait DNA manufacturing market, 2018 - 2030 (USD Million)
  • Fig. 63 Key companies profiled